# Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying Anti-rheumatic Drugs

> **NCT01084668** · — · COMPLETED · sponsor: **Abbott** · enrollment: 46 (actual)

## Conditions studied

- Psoriasis Chronic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01084668
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2012-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01084668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01084668, "Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying Anti-rheumatic Drugs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01084668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*